The calcium channel blocker nitrendipine attenuates renal and glomerular hypertrophy in diabetic rats

B Nielsen1, H Gronbaek, R Osterby

  • 1Institute of Experimental Clinical Research, M-Laboratory II, University Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark. BirgitteNielsen@dadlnet.dk

Insights

Nitrendipine, a calcium channel blocker, effectively reduced kidney and glomerular hypertrophy in diabetic rats. This treatment showed a trend towards lowering urinary albumin excretion without impacting blood pressure.

Area of Science:

  • Nephrology
  • Pharmacology
  • Diabetology

Background:

  • Diabetic nephropathy is a major complication of diabetes, characterized by renal hypertrophy and increased urinary albumin excretion (UAE).
  • Early intervention is crucial to mitigate kidney damage in diabetes.

Purpose of the Study:

  • To investigate the efficacy of the calcium channel blocker nitrendipine in preventing early renal and glomerular hypertrophy and increased UAE in experimental diabetes.
  • To assess the impact of nitrendipine on systemic blood pressure and metabolic control in diabetic rats.

Main Methods:

  • Female Wistar rats were randomized into four groups: diabetic and non-diabetic, treated with either placebo or nitrendipine (250 mg/kg) in the diet for 8 weeks.
  • Kidney weight, glomerular hypertrophy, UAE, systemic blood pressure, and metabolic control parameters were measured.

Main Results:

  • Diabetic rats exhibited significant renal and glomerular hypertrophy compared to non-diabetic controls.
  • Nitrendipine treatment significantly reduced renal and glomerular hypertrophy in diabetic rats (p < 0.05).
  • UAE remained stable in nitrendipine-treated diabetic rats, while it increased steadily in placebo-treated diabetic rats (p < 0.05). No significant differences in blood pressure were observed.

Conclusions:

  • Nitrendipine administration effectively inhibited renal and glomerular hypertrophy in diabetic rats.
  • Nitrendipine showed a tendency to reduce UAE in diabetic rats (p = 0.06) without affecting metabolic control or systemic blood pressure.
  • These findings suggest a potential renoprotective role for nitrendipine in early experimental diabetic nephropathy.

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...